Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels

Details for Australian Patent Application No. 2007323351 (hide)

Owner Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A.

Inventors Biondi, Giuseppe; Guglielmotti, Angelo

Agent Griffith Hack

Pub. Number AU-A-2007323351

PCT Pub. Number WO2008/061671

Priority MI2006A002254 24.11.06 IT

Filing date 13 November 2007

Wipo publication date 29 May 2008

International Classifications

A61K 31/416 (2006.01) - condensed with carbocyclic ring systems, e.g. indazole

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/061671 Priority application(s): WO2008/061671

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007323357-Transdermal therapeutic system comprising ion pair micro-reservoirs

2007323336-5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as CXCR2 antagonists